References
Muraguchi, A.; Butler, J.R.; Kehrl, J.H.; Fauci, A.S.: Differential sensitivity of human B cell subsets to activation signals delivered by anti-μ antibody and proliferative signals delivered by a monoclonal B cell growth factor. J. exp. Med.157: 530–546 (1983).
Yoshizaki, K.; Nakagawa, T.; Kaieda, T.; Muraguki, A.; Yamamura, Y.; Kishimoto, T.: Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulin and T cell factors. J. Immun.128: 1296–1301 (1982).
Viteta, E.S.; O'Hara, J.; Myers, C.D.; Layton, J.E.; Krammer, P.H.; Paul, W.E.: Serological, biochemical and functional identity of B-cell stimulatory factor 1 and B cell differentiation factor for IgG1. J. exp. Med.162: 1726–1731 (1985).
Cambier, J.C.: Seeing the way to B-cell growth. Nature319: 620 (1986).
Jurgensen, C.H.; Ambrus, J.L.; Fauci, A.S.: Production of B cell growth factor by normal human B cells. J. Immun.136: 4542–4547 (1986).
Muraguchi, A.; Nishimoto, H.; Kawamura, N.; Hori, A.; Kishimoto, T.: B cell derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. J. Immun.137: 179–186 (1986).
Blazar, B.A.; Sutton, L.M.; Strome, M.: Self-stimulating growth factor production by B cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Cancer Res.43: 4562–4568 (1983).
Gordon, J.; Ley, S.C.; Melamed, M.D.; Aman, P.; Hughes, N.C.: Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr Virus. J. exp. Med.159: 1554–1559 (1984).
Gordon, J.; Ley, S.C.; Melamed, M.D.; English, L.S.; Hughes-Jones, N.C.: Immortalized B lymphocytes produce B-cell growth factor. Nature310: 145–147 (1984).
Muraguchi, A.; Kishimoto, T.; Miki, Y.; Kuritani, T.; Kaieda, T.; Yoshizaki, K.; Yamamura, Y.: T cell replacing factor (TRF)-induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J. Immun.127: 412–416 (1981).
Haars, R.; Rohowsky-Kochan, C.; Reed, E.; King, D.W.; Suciu-Foca, N.: Modulation of T-cell antigen receptor on lymphocyte membrane. Immunogenetics20: 397–405 (1984).
Goding, J.W.: Conjugation of antibodies with fluorochromes: modification of the standard methods. J. immunol. Methods13: 215–226 (1976).
Salacinski, P.R.P.; McLean C.; Sykes, J.E.; Clement-Jones, V.V.; Lowry, P.J.: Iodination of proteins, glycoproteins and peptides using a solid-phase oxidizing agent, 1,3,4,6-tertrachloro-3d,6d-diphenyl glycoluril (Iodogen). Analyt. Biochem.117: 136–146 (1981).
Chirgivin, J.M.; Przybyla, A.E.; MacDonald, J.; Rutter, W.J.: Isolation of biologically active neonucleic acid from sources enriched in ribonuclease. Biochemistry18: 5294–5299 (1979).
Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature227: 680–685 (1970).
Suciu-Foca, N.; MacKenzie, W.; Ng, A.; Cai, J.; King, D.W.; A late differentiation antigen associated with the helper inducer function of human T cells. Nature318: 465–467 (1985).
Welte, K.; Andreeff, M.; Platzer, E.; Holloway, K.; Rubin, B.Y.; Moore, M.A.; Mertelsmann, R.: Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. J. exp. Med.160: 1390–1402 (1984).
Roth, P.; Halper, J.P.; Weinstein, B.; Pernis, B.: A phorbal ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells. J. Immun.129: 539–544 (1982).
Weinstein, I.B.; Arcoleo, J.; Lambert, M.; Hsiao, W.; Gattoni-Celli, S.; Jeffrey, A.M.; Kirschmeier, P.: Molecular mechanisms of multistage chemical carcinogenesis; in Wahren, Holm, Hammerstrom, Periman, Progress in cancer research and therapy, vol. 32: Molecular biology of tumor cells (Raven Press, New York 1985).
Ravetch, J.V.; Siebenlist, U.; Korsmeyer, S.; Waldmann, T.; Leder, P.: Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged. J and D genes. Cell27: 583–591 (1981).
Schreiber, P.; Lax, I.; Yarden, Y.; Eshhar, Z.; Schessinger, J.: Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effect of epidermal growth factor. Proc. nata. Acad. Sci. USA78: 7535–7539 (1981).
Clark, E.A.; Shu, G.; Ledbetter, J.: Role of the Bp35 cell surface polypeptide in human B cell activation. Proc. natn. Acad. Sci. USA82: 1766–1770 (1985).
Jung, L.K.L.; Fu, S.M.: Selective inhibition of growth factor dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells. J. exp. Med.160: 1919–1924 (1985).
Kikutani, H.; Kimura, R.; Nakamura, H.; Sato, R.; Muraguki, A.; Kawamura, N.; Hardy, R.R.; Kishimoto, T.: Expression and function of an early activation marker restricted to human B cells. J. Immun.135: 4019–4026 (1986).
Mishra, G.C.; Berton, M.T.; Oliver, K.G.; Krammer, P.H.; Uhr, T.W.; Viteta, E.S.: A mouse LFA-1 α-antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1). J. Immun.137: 1590–1598 (1986).
Waldman, T.A.: The structure, function and expression of IL-2 receptors on normal and malignant lymphocytes. Science232: 727–732 (1986).
Tedder, T.F.; Boyd, A.W.; Freedman, A.S.; Nadler, L.M.; Schlossman, S.I.: The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J. Immun.135: 973–976 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suciu-Foca, N., Rohowsky-Kochan, C., Rosochacki, S.J. et al. NDA3: A differentiation antigen associated with the receptor for B cell growth factor. Immunol Res 5, 165–172 (1986). https://doi.org/10.1007/BF02919198
Issue Date:
DOI: https://doi.org/10.1007/BF02919198